AXOL BIOSCIENCE LTD.

In News

Axol Bioscience acquires ophthalmology business from Newcells Biotech - News-Medical

News-Medical - Feb 18, 2026

Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development - BioSpace

BioSpace - Jan 14, 2026

Axol Bioscience Ltd. Acquires Ophthalmology Business of Newcells Biotech - The Indian Practitioner

The Indian Practitioner - Feb 19, 2026

Venture Capital Funding Flowing into the iPSC Sector by Year - bioinformant.com

bioinformant.com - Aug 03, 2025

Jobs saved in biotech firm’s acquisition deal - pressreader.com

pressreader.com - Feb 19, 2026

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery - the-scientist.com

the-scientist.com - Aug 02, 2022

Axol Bioscience acquires Phenocell to advance human disease models - News-Medical

News-Medical - Oct 22, 2024

eBook: Using iPSCs models for human disease research and drug discovery - News-Medical

News-Medical - Aug 30, 2024

Validation of a cortical tri-culture axoModel™ for in vitro compound screening: A blinded compound study - News-Medical

News-Medical - Nov 18, 2024

Advanced Cardiotoxicity Testing Using Multi-Channel iPSC Cardiomyocytes - News-Medical

News-Medical - Sep 20, 2024

Validating a tri-culture cortical model to advance neurodegenerative drug discovery - News-Medical

News-Medical - Sep 16, 2024

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease - News-Medical

News-Medical - Nov 28, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment